Skip to main content
SpringerLink
Log in

The Bright Side of Bird Flu

Potential Pandemic Boosts Pharmaceutical Products and Pipeline

  • Emerging technology
  • Published:
Pharmaceutical & Diagnostic Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Datamonitor. Herpes and respiratory antivirals: avian flu catalyst for maintaining market growth. Media release: 10 Nov 2005

    Google Scholar 

  2. US Biotechnology. Influenza: disease trends, market dynamics and new technologies. New York: Lehman Brothers Global Equity Research, 2005

    Google Scholar 

  3. Novel polymer advancing vaccine technology: potential to eliminate cold-chain system. Pharm Diagn Innov 2005; 7 (3): 11–2

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The Bright Side of Bird Flu. Pharmaceutical & Diagnostic Innovation 4, 11–13 (2006). https://doi.org/10.1007/BF03257032

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03257032

Keywords

Search

Navigation